Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis | MicrobiomeTrials← Back to trialsNCT00315380
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
RecruitingOBSERVATIONAL
Trial Details
Start: 2006-04Est. Completion: 2028-12
Enrollment target: 700 participants Locations- University of California San Diego, San Diego, California, United States
- National Jewish Health, Denver, Colorado, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Cleveland Clinic Foundation, Cleveland, Ohio, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- University of Pittsburgh, Pittsburgh, Pennsylvania, United States
- University of Utah, Salt Lake City, Utah, United States
- St. Joseph's Healthcare, Hamilton, Ontario, Canada
- Mount Sinai Hospital, Toronto, Ontario, Canada
- medius KLINIK KIRCHHEIM, Kirchheim unter Teck, Germany
- AOU Meyer IRCCS, Florence, Italy
- Cambridge University Hospitals Nhs Foundation Trust, Cambridge, United Kingdom
- Imperial College Healthcare NHS Trust/ Imperial College London, London, United Kingdom
- Guy'S and St Thomas' Nhs Foundation Trust, London, United Kingdom
Other microbiome trials you might be interested in
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA)
This observational study aims to evaluate the long-term effectiveness and safety of mepolizumab 300 mg/4 weeks in adults…
Florence, ItalyCompleted Mar 31, 2026
Eosinophilic Granulomatosis With Polyangiitis (EGPA)
This is a multicenter, retro-prospective observational study evaluating the effectiveness and safety of benralizumab in …
Florence, ItalyEst. completion Feb 11, 2027